Humoral immunity in renal transplantation: clinical significance and therapeutic approach

Authors: Rowshani, Ajda T.1; Bemelman, Frederieke J.1; Lardy, Neubury M.2; ten Berge, Ineke J.M.1

Source: Clinical Transplantation, Volume 22, Number 6, November/December 2008 , pp. 689-699(11)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Rowshani AT, Bemelman FJ, Lardy NM, ten Berge IJM. Humoral immunity in renal transplantation: clinical significance and therapeutic approach.

Clin Transplant 2008: 22: 689-699. © 2008 Wiley Periodicals, Inc. Abstract: 

Donor-specific antibodies (DSA) form a significant barrier in solid organ transplantation of highly pre-sensitized candidates. Although avoiding transplantation over a positive cross-match test can largely prevent the occurrence of hyperacute antibody-mediated rejection, transplantation of highly pre-sensitized candidates is often complicated by the occurrence of acute and chronic antibody-mediated graft rejection leading to diminished graft function and survival. The pre-existent HLA and/or non-HLA-specific antibodies are without any doubt important contributing factors underlying humoral-mediated graft injury. Furthermore, increasing evidence underlines the association of newly formed de novo DSA after transplantation with poor graft function and survival. There is still a need to further develop desensitizing therapies not only to make transplantation of highly pre-sensitized candidates feasible, but also to reduce the new formation of allo-antibodies. Here, we summarize current views on desensitization therapies and the impact of the presence of DSA on the fate of the kidney graft.

Keywords: anti-CD20 monoclonal antibodies; chronic antibody-mediated rejection; desensitization; donor-specific allo-antibodies; humoral rejection; kidney transplantation

Document Type: Review article

DOI: 10.1111/j.1399-0012.2008.00872.x

Affiliations: 1: Department of Internal Medicine, Renal Transplant Unit, Academic Medical Center, Amsterdam 2: HLA Diagnostics Laboratory, Sanquin, Amsterdam, the Netherlands

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$49.48 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A